Multivariate analysis showed that YTHDF2 expression was an independent risk factor for tumor progression (TCGA-KIRC cohort: OS, HR = 0.615, 95% CI: 0.405–0.934; p < 0.05) (Figure 4A). This evidence concerns the gene YTHDF2 and neoplasm.